These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 20955832)

  • 21. Toll-like receptors and their role in gastrointestinal disease.
    Testro AG; Visvanathan K
    J Gastroenterol Hepatol; 2009 Jun; 24(6):943-54. PubMed ID: 19638078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How important are Toll-like receptors for antimicrobial responses?
    Carpenter S; O'Neill LA
    Cell Microbiol; 2007 Aug; 9(8):1891-901. PubMed ID: 17521328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Innate immunity: toll-like receptors and some more. A brief history, basic organization and relevance for the human newborn.
    Fleer A; Krediet TG
    Neonatology; 2007; 92(3):145-57. PubMed ID: 17476116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ampligen: a potential toll-like 3 receptor adjuvant for immunotherapy of cancer.
    Jasani B; Navabi H; Adams M
    Vaccine; 2009 May; 27(25-26):3401-4. PubMed ID: 19200817
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression and function of toll-like receptors at the maternal-fetal interface.
    Koga K; Mor G
    Reprod Sci; 2008 Apr; 15(3):231-42. PubMed ID: 18421019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Signaling to NF-kappaB by Toll-like receptors.
    Kawai T; Akira S
    Trends Mol Med; 2007 Nov; 13(11):460-9. PubMed ID: 18029230
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulatory T cells and Toll-like receptors in tumor immunity.
    Wang RF; Peng G; Wang HY
    Semin Immunol; 2006 Apr; 18(2):136-42. PubMed ID: 16469504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of Toll-like receptors in the pathogenesis of renal disease.
    Czyzyk J
    Semin Nephrol; 2006 Mar; 26(2):167-72. PubMed ID: 16530608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decoding dangerous death: how cytotoxic chemotherapy invokes inflammation, immunity or nothing at all.
    van der Most RG; Currie AJ; Robinson BW; Lake RA
    Cell Death Differ; 2008 Jan; 15(1):13-20. PubMed ID: 18007666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toll-like receptors in tonsillar epithelial cells.
    Lange MJ; Lasiter JC; Misfeldt ML
    Int J Pediatr Otorhinolaryngol; 2009 Apr; 73(4):613-21. PubMed ID: 19167100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TLR signaling.
    Kawai T; Akira S
    Semin Immunol; 2007 Feb; 19(1):24-32. PubMed ID: 17275323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TLRs and chronic inflammation.
    Ospelt C; Gay S
    Int J Biochem Cell Biol; 2010 Apr; 42(4):495-505. PubMed ID: 19840864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The significance of toll-like receptors in human diseases.
    Montero Vega MT; de Andrés Martín A
    Allergol Immunopathol (Madr); 2009; 37(5):252-63. PubMed ID: 19853360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Toll-like receptors: from the discovery of NFkappaB to new insights into transcriptional regulations in innate immunity.
    Doyle SL; O'Neill LA
    Biochem Pharmacol; 2006 Oct; 72(9):1102-13. PubMed ID: 16930560
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TRAF3: a new component of the TLR-signaling apparatus.
    Hoebe K; Beutler B
    Trends Mol Med; 2006 May; 12(5):187-9. PubMed ID: 16621716
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Innate immunity of the ocular surface.
    Ueta M; Kinoshita S
    Brain Res Bull; 2010 Feb; 81(2-3):219-28. PubMed ID: 19828129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathogen recognition and Toll-like receptor targeted therapeutics in innate immune cells.
    Tartey S; Takeuchi O
    Int Rev Immunol; 2017 Mar; 36(2):57-73. PubMed ID: 28060562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toll-like receptors: Triggers of regulated cell death and promising targets for cancer therapy.
    Yang Y; Feng R; Wang YZ; Sun HW; Zou QM; Li HB
    Immunol Lett; 2020 Jul; 223():1-9. PubMed ID: 32311408
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toll-like receptor stimulation in cancer: A pro- and anti-tumor double-edged sword.
    Dajon M; Iribarren K; Cremer I
    Immunobiology; 2017 Jan; 222(1):89-100. PubMed ID: 27349597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toll-like receptors in breast cancer immunity and immunotherapy.
    Zhou J; Zhang L; Liu S; DeRubeis D; Zhang D
    Front Immunol; 2024; 15():1418025. PubMed ID: 38903515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.